ATE238348T1 - Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen - Google Patents

Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen

Info

Publication number
ATE238348T1
ATE238348T1 AT96939132T AT96939132T ATE238348T1 AT E238348 T1 ATE238348 T1 AT E238348T1 AT 96939132 T AT96939132 T AT 96939132T AT 96939132 T AT96939132 T AT 96939132T AT E238348 T1 ATE238348 T1 AT E238348T1
Authority
AT
Austria
Prior art keywords
compositions containing
medications
peptides derived
thymic hormones
conjugate peptides
Prior art date
Application number
AT96939132T
Other languages
English (en)
Inventor
D Hinterland Lucien Dussourd
Anne-Marie Pinel
Original Assignee
Inst Europeen Biolog Cellulair
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Europeen Biolog Cellulair filed Critical Inst Europeen Biolog Cellulair
Application granted granted Critical
Publication of ATE238348T1 publication Critical patent/ATE238348T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/062—Serum thymic factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AT96939132T 1995-11-15 1996-11-15 Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen ATE238348T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9513544A FR2741076B1 (fr) 1995-11-15 1995-11-15 Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
PCT/FR1996/001812 WO1997018239A1 (fr) 1995-11-15 1996-11-15 Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant

Publications (1)

Publication Number Publication Date
ATE238348T1 true ATE238348T1 (de) 2003-05-15

Family

ID=9484596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96939132T ATE238348T1 (de) 1995-11-15 1996-11-15 Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen

Country Status (10)

Country Link
US (1) US6211155B1 (de)
EP (1) EP0861266B3 (de)
JP (1) JP2000500447A (de)
AT (1) ATE238348T1 (de)
AU (1) AU7683296A (de)
CA (1) CA2237995C (de)
DE (2) DE69627691T4 (de)
ES (1) ES2196187T7 (de)
FR (1) FR2741076B1 (de)
WO (1) WO1997018239A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030948A (en) * 1997-12-19 2000-02-29 Mann; Morris A. Hair regeneration compositions for treatment of alopecia and methods of application related thereto
US6462019B1 (en) * 1998-07-10 2002-10-08 Osteoscreen, Inc. Inhibitors of proteasomal activity and production for stimulating bone growth
US6902721B1 (en) * 1998-07-10 2005-06-07 Osteoscreen, Inc. Inhibitors of proteasomal activity for stimulating bone growth
US20070015698A1 (en) * 1998-07-30 2007-01-18 United States Of America As Represented By The Secretary Of Health Treatment of skin, and wound repair, with thymosin beta 4
PT1100529E (pt) * 1998-07-30 2005-10-31 Us Gov Health & Human Serv A timosina beta 4 promove a preparacao de feridas
FR2857597B1 (fr) * 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
FR2857667B1 (fr) 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie
EP1680438A2 (de) * 2003-10-14 2006-07-19 Kernel Biopharma Inc. Amphiphile peptid-pna-konjugate zum transport von pna über die blut-hirn-schranke
ES2355571T3 (es) * 2004-03-26 2011-03-29 Dsm Ip Assets B.V. Conjugados de ácidos arilalquílicos con aminoácidos y péptidos para usos cosméticos.
FR2899105B1 (fr) * 2006-03-30 2012-07-27 Soc Extraction Principes Actif Composition cosmetique et/ou pharmaceutique comprenant comme ingredient actif, au moins un hydrolysat de proteines de poacees et utilisation de cet hydrolysat
CN101855235B (zh) * 2007-10-29 2013-04-24 赫里克斯生物医疗公司 保护性皮肤护理四肽
EP2227218A2 (de) * 2007-11-30 2010-09-15 Immundiagnostik AG Zusammensetzung zur behandlung und prävention von haarausfall und vorzeitiger ergrauung des haars
FR3042192B1 (fr) 2015-10-09 2017-12-08 Inst Europeen De Biologie Cellulaire Peptides utiles dans le traitement preventif et curatif de l'alopecie
US20180228837A1 (en) * 2017-02-15 2018-08-16 Tanya Rhodes Stable iodine solutions with medical applications
CU24626B1 (es) 2019-12-26 2022-11-07 Centro Nac De Biopreparados Composición farmacéutica a base de proteínas con actividad neuroprotectora, inmunomoduladora, antiinflamatoria y antimicrobiana

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156766B (it) * 1977-05-25 1987-02-04 Anvar Polipeptidi dotati di attivita' timica o antagonista e procedimento per la loro sintesi
NZ189101A (en) * 1977-12-08 1984-07-06 Ortho Pharma Corp Polypeptides having the ability to induce differentiation of both th-1+ t-lymphocytes and bu-1+ b-lymphocytes;pharmaceutical compositions
JPS5852225A (ja) * 1981-09-22 1983-03-28 Mitsui Pharmaceut Inc 脱髄疾患治療剤
JPS6089499A (ja) * 1983-10-21 1985-05-20 Mitsui Pharmaceut Inc ペプチド
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs

Also Published As

Publication number Publication date
AU7683296A (en) 1997-06-05
US6211155B1 (en) 2001-04-03
WO1997018239A1 (fr) 1997-05-22
EP0861266B1 (de) 2003-04-23
ES2196187T3 (es) 2003-12-16
EP0861266A1 (de) 1998-09-02
FR2741076B1 (fr) 1998-01-30
ES2196187T7 (es) 2009-11-05
DE69627691T4 (de) 2009-10-08
CA2237995A1 (fr) 1997-05-22
JP2000500447A (ja) 2000-01-18
DE69627691T2 (de) 2004-03-11
EP0861266B3 (de) 2009-04-08
CA2237995C (fr) 2011-08-09
DE69627691D1 (de) 2003-05-28
FR2741076A1 (fr) 1997-05-16

Similar Documents

Publication Publication Date Title
ATE238348T1 (de) Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen
DE69627019D1 (de) PEPTIDKONJUGATE, DEREN VERWENDUNG ALS HEILMITTEL UND ZUSAMMENSeTZUNGen, DIEse ENTHALTENd
DK2016950T3 (da) Farmaceutisk sammensætning omfattende et exendin-4-peptid
ES2163444T3 (es) Composiciones y metodos para la administracion oral de farmacos.
ATE308998T1 (de) Langwirkende arzneistoffe und diese enthaltende arzneimittel
FI945912A0 (fi) Proteinoidikantajat ja menetelmät niiden valmistamiseksi sekä niiden käyttö
WO2000012542A3 (en) Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
CA2134348A1 (en) Polysaccharide derivatives and drug carriers
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
DE69830492D1 (de) Antikörper als ARZNEIMITTEL GEGEN LYMPHOCYTISCHE TUMORE (AUSSCHLIESSLICH MYELOME)
FR2768341B1 (fr) Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides
EP2046813B1 (de) Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel
TR199902575T2 (xx) Peptitler, proteinler ve nükleik asitler için stabil farmasötik uygulama formu.
ATE216234T1 (de) Zusammensetzungen aus aminosäure zur behandlung von infektionen
KR970058720A (ko) 향균 및 항진균 활성을 갖는 펩타이드
KR970058721A (ko) 향균 및 항진균 활성을 갖는 펩타이드
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.
TH35998A (th) Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น
KR840007567A (ko) 펩티드의 제조방법
KR910004663A (ko) 정신-약리학적 펩티드

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties